Search

Your search keyword '"Eleftheriou, Despina"' showing total 620 results

Search Constraints

Start Over You searched for: Author "Eleftheriou, Despina" Remove constraint Author: "Eleftheriou, Despina"
620 results on '"Eleftheriou, Despina"'

Search Results

1. Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis

3. Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

5. Lifetime cardiovascular management of patients with previous Kawasaki disease

8. OA36 Systemic juvenile idiopathic arthritis: the Great Ormond Street Hospital experience (2005-2021)

9. The pediatric glucocorticoid toxicity index

12. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort

13. Genetic Interferonopathies

14. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)

15. Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition

16. Genetic testing of Behçet’s disease using next-generation sequencing to identify monogenic mimics and HLA-B*51

19. Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matching

20. Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4

24. Application and performance of disease activity indices proposed for patients with systemic sclerosis in an international cohort of patients with juvenile systemic sclerosis

25. Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matching

30. Vasculitis update: pathogenesis and biomarkers

31. Efficacy and safety of emapalumab in macrophage activation syndrome

36. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management

37. Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort

38. Efficacy and safety of emapalumab in macrophage activation syndrome

43. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest jSSc cohort of the world. Results from the the juvenile scleroderma inception cohort

44. Juvenile systemic sclerosis treatment practices in an international cohort and comparison to recent SHARE consensus guidelines

45. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 12 months observation period in the juvenile systemic scleroderma inception cohort

Catalog

Books, media, physical & digital resources